These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15485495)

  • 1. Detecting bioactive amyloid beta peptide species in Alzheimer's disease.
    Liu Y; Dargusch R; Banh C; Miller CA; Schubert D
    J Neurochem; 2004 Nov; 91(3):648-56. PubMed ID: 15485495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The formation of bioactive amyloid species by prion proteins in vitro and in cells.
    Liu Y; Ritter C; Riek R; Schubert D
    Neurosci Lett; 2006 Oct; 406(3):200-4. PubMed ID: 16916580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cell-based method for the detection of nanomolar concentrations of bioactive amyloid.
    Liu Y; Piasecki D
    Anal Biochem; 2001 Feb; 289(2):130-6. PubMed ID: 11161306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation.
    White JA; Manelli AM; Holmberg KH; Van Eldik LJ; Ladu MJ
    Neurobiol Dis; 2005 Apr; 18(3):459-65. PubMed ID: 15755672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of microsomal epoxide hydrolase is elevated in Alzheimer's hippocampus and induced by exogenous beta-amyloid and trimethyl-tin.
    Liu M; Sun A; Shin EJ; Liu X; Kim SG; Runyons CR; Markesbery W; Kim HC; Bing G
    Eur J Neurosci; 2006 Apr; 23(8):2027-34. PubMed ID: 16630050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
    Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
    Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible role of scavenger receptor SRCL in the clearance of amyloid-beta in Alzheimer's disease.
    Nakamura K; Ohya W; Funakoshi H; Sakaguchi G; Kato A; Takeda M; Kudo T; Nakamura T
    J Neurosci Res; 2006 Sep; 84(4):874-90. PubMed ID: 16868960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
    Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
    J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.
    Bruno MA; Leon WC; Fragoso G; Mushynski WE; Almazan G; Cuello AC
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):857-69. PubMed ID: 19606067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes.
    Hüll M; Müksch B; Akundi RS; Waschbisch A; Hoozemans JJ; Veerhuis R; Fiebich BL
    Neurochem Int; 2006 Jun; 48(8):663-72. PubMed ID: 16546299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of MTT formazan in lipid droplets. An alternative hypothesis about the nature of formazan granules and aggregates.
    Diaz G; Melis M; Musin A; Piludu M; Piras M; Falchi AM
    Eur J Histochem; 2007; 51(3):213-8. PubMed ID: 17921117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study.
    Cheng H; Xu J; McKeel DW; Han X
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):809-18. PubMed ID: 14528918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis.
    Liu Y; Schubert D
    J Neurochem; 1997 Dec; 69(6):2285-93. PubMed ID: 9375659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abeta-globulomers are formed independently of the fibril pathway.
    Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
    Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis.
    Dedeoglu A; Cormier K; Payton S; Tseitlin KA; Kremsky JN; Lai L; Li X; Moir RD; Tanzi RE; Bush AI; Kowall NW; Rogers JT; Huang X
    Exp Gerontol; 2004; 39(11-12):1641-9. PubMed ID: 15582280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.
    Donovan MH; Yazdani U; Norris RD; Games D; German DC; Eisch AJ
    J Comp Neurol; 2006 Mar; 495(1):70-83. PubMed ID: 16432899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.